Anzeige
Mehr »
Login
Samstag, 11.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Innocan Pharma News: Unfassbare Studie - LPT-Therapie bewahrt Patient vor dem Tod!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
124 Leser
Artikel bewerten:
(0)

Solvay S.A.: Outcome of Solvay's General Shareholders Meeting

Brussels, May 8, 2018 --- Solvay today held its General Shareholders Meeting at its Corporate Headquarters in Brussels.

Shareholders voted in favor of all the resolutions proposed. More specifically, they approved the payment of a gross dividend of € 3.60 per share for the fiscal year 2017. After deduction of the prepayment made on January 18, 2018 of € 1.38 gross per share, the balance of the gross dividend amounts to € 2.22 gross per share, payable as of May 23, 2018.

During the General Shareholders Meeting, shareholders also approved the re-election of Mrs. Rosemary Thorne and Mr. Gilles Michel as independent Board Members on the Board of Directors for a four-year term until May 2022. Mr. Philippe Tournay and Mr Matti Lievonen were nominated as independent members on the Board of Directors for four years in replacement of Mr. Denis Solvay and Mr. Bernhard Scheuble who have decided not to request the renewal of their mandate as Board members.

Details of the resolutions and voting results as well as a replay of the shareholder meeting are available on Solvay's website, Investors section (https://www.solvay.com/en/investors/shareholders-meeting/2018/index.html).

Follow us on twitter @SolvayGroup (https://twitter.com/SolvayGroup)

Solvay is an advanced materials and specialty chemicals company, committed to developing chemistry that addresses key societal challenges. Solvay innovates and partners with customers worldwide in many diverse end markets. Its products are used in planes, cars, batteries, smart and medical devices, as well as in mineral and oil and gas extraction, enhancing efficiency and sustainability. Its lightweighting materials promote cleaner mobility, its formulations optimize the use of resources and its performance chemicals improve air and water quality. Solvay is headquartered in Brussels with around 24,500 employees in 61 countries. Net sales were €10.1 billion in 2017, with 90% from activities where Solvay ranks among the world's top 3 leaders, resulting in an EBITDA margin of 22%. Solvay SA (SOLB.BE) is listed on Euronext Brussels and Paris (Bloomberg: SOLB.BB - Reuters: SOLB.BR) and in the United States its shares (SOLVY) are traded through a level-1 ADR program.
Figures take into account the announced divestment of Polyamides.

Media Relations
Caroline Jacobs (mailto:caroline.jacobs@solvay.com) Amandine Grison (mailto:amandine.grison@solvay.com)
+32 2 264 1530 +33 1 40 75 81 49

Investor Relations
Kimberly Stewart (mailto:kimberly.stewart@solvay.com) Jodi Allen (mailto:jodi.allen@solvay.com) Geoffroy Raskin (mailto:geoffroy.raskin@solvay.com) Bisser Alexandrov (mailto:bisser.alexandrov@solvay.com)
+32 2 264 3694 +1 6098604608 +32 2 264 1540 +32 2 264 3687
To read this release in PDF (http://hugin.info/133981/R/2190949/848239.pdf)



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Solvay S.A. via Globenewswire

Lithium vs. Palladium - Ist das die Chance des Jahrzehnts?
Sichern Sie sich den kostenlosen PDF-Report! So können Sie vom Boom der Rohstoffe profitieren.
Hier klicken
© 2018 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.